logo
Dan Ives names his favorite ways to play the AI revolution from here

Dan Ives names his favorite ways to play the AI revolution from here

CNBC08-05-2025

While President Donald Trump's tariffs have spurred worries among investors that they could threaten the artificial intelligence boom, Wedbush analyst Dan Ives thinks it's still full-steam ahead for the industry. "The strong are going to get stronger," Ives said during CNBC's " Squawk on the Street " on Thursday. "Even what we've seen in earnings season, this is an AI revolution. Tariffs are not stopping it." Noting that the global semiconductor market is anticipated to reach $1.7 trillion to $2.4 trillion by 2040, Ives – who will be discussing AI at CNBC Pro's live event next month – looked for several companies that "define the future of the AI theme over the coming years." This comes amid increasing demand for the technology beyond Nvidia's chips, as Ives estimates that for every $1 spent on Nvidia, there is between an $8 and $10 multiplier for the rest of the tech ecosystem. "Now the time has come for the broader software space to get in on the AI Revolution as we believe the use cases are exploding, enterprise consumption phase is ahead of us in the rest of 2025, launch of LLM models across the board, and the true adoption of generative AI will be a major catalyst for the software sector and key players to benefit from this once in a generation 4th Industrial Revolution set to benefit the tech space," the analyst wrote in a Wednesday note. Here are some of the names to play the AI revolution, according to Ives. In the semis space, Nvidia is a clear AI play, with Ives saying that the chipmaker "remains the undisputed leading supplier of GPUs into numerous high growth markets, including gaming and data center applications." Although shares have fallen more than 12% this year, lagging the broader market, they've jumped more than 22% in the past month. That gain has outperformed the S & P 500's more than 14% rise in the same period. "We view Nvidia's intermediate term growth profile as likely to parallel broader favorable consumption/investment trends in these industries, bolstered by ramping Blackwell projects and large private and sovereign AI investments," Ives wrote in the recent note. Among the consumer internet names Ives selected, Ives thinks Chinese tech giant Baidu is a name to consider, even with U.S.-China trade tensions. U.S.-listed shares have risen almost 4% this year, compared to the S & P 500's nearly 3% decline in the period. The stock has also gained close to 14% in the past month. "BIDU represents a major AI player in China as its comprehensive platform offers a robust foundation to develop and deploy these solutions to drive growth and cut costs," the analyst also wrote. In March, Baidu released two new AI models , one of which has reasoning capabilities that the company said rival DeepSeek's R1 model. Additionally, data storage company Snowflake is a name investors should eye among key software names. Snowflake shares have soared almost 31% in the past month and more than 13% year to date. "With SNOW now providing easy-to-use GenAI solutions through Cortex which leverages best-in-class models with fully managed infrastructure, the company is well-positioned to continue building its AI pipeline over the coming quarters by making this technology accessible to every organization across industries," Ives wrote.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Israel launches 'preemptive' strikes on Iran
Israel launches 'preemptive' strikes on Iran

Yahoo

time14 minutes ago

  • Yahoo

Israel launches 'preemptive' strikes on Iran

Israel carried out "preemptive" strikes against Iran on Friday, targeting its nuclear plant and military sites, after US President Donald Trump warned of a possible "massive conflict" in the region. Explosions were heard Friday morning in the Iranian capital, state TV reported, adding that Iran's air defence were at "100 percent operational capacity". Israel declared a state of emergency, with Defence Minister Israel Katz saying that retaliatory action from Tehran was possible following the operation. "Following the State of Israel's preemptive strike against Iran, a missile and drone attack against the State of Israel and its civilian population is expected in the immediate future," Katz said. Oil prices surged as much as 6 percent on the strikes, which came after Trump warned of a possible Iranian attack and said the US was drawing down staff in the region. "I don't want to say imminent, but it looks like it's something that could very well happen," Trump told reporters at the White House Thursday when asked if an Israeli attack loomed. Trump said he believed a "pretty good" deal on Iran's nuclear programme was "fairly close", but said that an Israeli attack on its arch foe could wreck the chances of an agreement. The US leader did not disclose the details of a conversation on Monday with Israeli Prime Minister Benjamin Netanyahu, but said: "I don't want them going in, because I think it would blow it." Trump quickly added: "Might help it actually, but it also could blow it." A US official said there had been no US involvement in the Israeli strikes on Iran. -- 'Extremist' -- The United States on Wednesday said it was reducing embassy staff in Iraq -- long a zone of proxy conflict with Iran. Israel, which counts on US military and diplomatic support, sees the cleric-run state in Tehran as an existential threat and hit Iranian air defences last year. Netanyahu has vowed less restraint since the unprecedented October 7, 2023 attack on Israel by Tehran-backed Hamas, which triggered the massive Israeli offensive in Gaza. The United States and other Western countries, along with Israel, have repeatedly accused Iran of seeking a nuclear weapon, which it has repeatedly denied. Israel again called for global action after the UN's International Atomic Energy Agency (IAEA) accused Iran on Wednesday of non-compliance with its obligations. The resolution could lay the groundwork for European countries to invoke a "snapback" mechanism, which expires in October, that would reinstate UN sanctions eased under a 2015 nuclear deal negotiated by then US president Barack Obama. Trump pulled out of the deal in his first term and slapped Iran with sweeping sanctions. Iran's nuclear chief, Mohammad Eslami, slammed the resolution as "extremist" and blamed Israeli influence. In response to the resolution, Iran said it would launch a new enrichment centre in a secure location. Iran would also replace "all of these first-generation machines with sixth-generation advanced machines" at the Fordo uranium enrichment plant, said Behrouz Kamalvandi, spokesman of the Atomic Energy Organization of Iran. Iran currently enriches uranium to 60 percent, far above the 3.67-percent limit set in the 2015 deal and close, though still short, of the 90 percent needed for a nuclear warhead. bur-hmn/tym

Viking Therapeutics, Inc. (VKTX) Stock Drops Despite Market Gains: Important Facts to Note
Viking Therapeutics, Inc. (VKTX) Stock Drops Despite Market Gains: Important Facts to Note

Yahoo

time16 minutes ago

  • Yahoo

Viking Therapeutics, Inc. (VKTX) Stock Drops Despite Market Gains: Important Facts to Note

Viking Therapeutics, Inc. (VKTX) closed at $28.59 in the latest trading session, marking a -1.26% move from the prior day. The stock's performance was behind the S&P 500's daily gain of 0.38%. On the other hand, the Dow registered a gain of 0.24%, and the technology-centric Nasdaq increased by 0.24%. Prior to today's trading, shares of the company had gained 8.96% outpaced the Medical sector's gain of 4.64% and the S&P 500's gain of 6.6%. The investment community will be paying close attention to the earnings performance of Viking Therapeutics, Inc. in its upcoming release. The company is expected to report EPS of -$0.44, down 120% from the prior-year quarter. Regarding the entire year, the Zacks Consensus Estimates forecast earnings of -$1.86 per share and revenue of $25 million, indicating changes of -84.16% and 0%, respectively, compared to the previous year. Investors should also note any recent changes to analyst estimates for Viking Therapeutics, Inc. Recent revisions tend to reflect the latest near-term business trends. Therefore, positive revisions in estimates convey analysts' confidence in the business performance and profit potential. Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system. The Zacks Rank system, which varies between #1 (Strong Buy) and #5 (Strong Sell), carries an impressive track record of exceeding expectations, confirmed by external audits, with stocks at #1 delivering an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate remained stagnant. Right now, Viking Therapeutics, Inc. possesses a Zacks Rank of #3 (Hold). The Medical - Biomedical and Genetics industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 74, which puts it in the top 31% of all 250+ industries. The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. Ensure to harness to stay updated with all these stock-shifting metrics, among others, in the next trading sessions. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Viking Therapeutics, Inc. (VKTX) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Sign in to access your portfolio

Starbucks (SBUX) Stock Slides as Market Rises: Facts to Know Before You Trade
Starbucks (SBUX) Stock Slides as Market Rises: Facts to Know Before You Trade

Yahoo

time16 minutes ago

  • Yahoo

Starbucks (SBUX) Stock Slides as Market Rises: Facts to Know Before You Trade

Starbucks (SBUX) closed the most recent trading day at $94.32, moving -1.12% from the previous trading session. The stock's change was less than the S&P 500's daily gain of 0.38%. Meanwhile, the Dow experienced a rise of 0.24%, and the technology-dominated Nasdaq saw an increase of 0.24%. Heading into today, shares of the coffee chain had gained 10.23% over the past month, outpacing the Retail-Wholesale sector's gain of 2.95% and the S&P 500's gain of 6.6%. Analysts and investors alike will be keeping a close eye on the performance of Starbucks in its upcoming earnings disclosure. The company is predicted to post an EPS of $0.66, indicating a 29.03% decline compared to the equivalent quarter last year. Alongside, our most recent consensus estimate is anticipating revenue of $9.29 billion, indicating a 1.94% upward movement from the same quarter last year. Regarding the entire year, the Zacks Consensus Estimates forecast earnings of $2.53 per share and revenue of $36.89 billion, indicating changes of -23.56% and +1.97%, respectively, compared to the previous year. Investors should also pay attention to any latest changes in analyst estimates for Starbucks. Recent revisions tend to reflect the latest near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the business outlook. Our research demonstrates that these adjustments in estimates directly associate with imminent stock price performance. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system. The Zacks Rank system, running from #1 (Strong Buy) to #5 (Strong Sell), holds an admirable track record of superior performance, independently audited, with #1 stocks contributing an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed a 1.46% decrease. At present, Starbucks boasts a Zacks Rank of #4 (Sell). Digging into valuation, Starbucks currently has a Forward P/E ratio of 37.67. For comparison, its industry has an average Forward P/E of 23.8, which means Starbucks is trading at a premium to the group. We can additionally observe that SBUX currently boasts a PEG ratio of 4.79. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. By the end of yesterday's trading, the Retail - Restaurants industry had an average PEG ratio of 2.53. The Retail - Restaurants industry is part of the Retail-Wholesale sector. This group has a Zacks Industry Rank of 178, putting it in the bottom 28% of all 250+ industries. The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. Be sure to use to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Starbucks Corporation (SBUX) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store